Most infants born with otoferlin deafness get cochlear implants in infancy and are hence ineligible to the demo. The implants somewhat alter the cochlea, which could hamper the interpretation of gene therapy results. The mutated otoferlin gene destroys a protein while in the interior ear’s hair cells important to https://artsuppliesonline.us/products/16x20-uncut-white-color-mat-board-center